Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Investment analysts at Brookline Capital Management issued their Q1 2024 earnings per share estimates for Verrica Pharmaceuticals in a research note issued on Monday, June 26th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn ($0.49) per share for the quarter. The consensus estimate […]